References: [1]. Andy Chi-Lung Lee, et al. A Comprehensive Review on Current Advances in Peptide Drug Development and Design, Int J Mol Sci. 2019 May 14;20(10):2383. [2]. 林梦君,宋晓燕,韩江升,闫华.生物活性肽产品开发及应用景[J].山东化工,2020.20.016 [3]. Huizi Wu, et al. Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance, Protein & Peptide Letters. 2018;25(6):514-521. [4]. Minzhi Yu, et al. Battle of GLP-1 Delivery Technologies, Adv Drug Deliv Rev . 2018 May;130:113-130. [5]. Christina Hartmann, et al. Angiotensin II-induced hypertension increases the mutant frequency in rat kidney, Arch Toxicol,2019 Jul;93(7):2045-2055.
版权声明